Beijing Centergate Technologies News

Beijing Centergate Technologies: Announcement regarding the receipt of the State Drug Administration's "Acceptance Notice" for the consistent evaluation application of tramadol hydrochloride injection by Dodo Pharmaceutical, a subsidiary company.

Jul 25 12:00 ET

Beijing Centergate Technologies: Announcement on the Progress of the Sustained-release Paroxetine Hydrochloride Chewable Tablets Project.

Jul 24 12:00 ET

Beijing Centergate Technologies: Notice regarding the convening of the fourth extraordinary shareholder meeting in 2024.

Jul 12 12:00 ET

Beijing Centergate Technologies: Announcement Regarding Adjustment of Company's Global Strategy

Jul 9 12:00 ET

Beijing Centergate Technologies: Announcement regarding litigation, arbitration and legal proceedings against subsidiary companies.

Jun 14 12:00 ET

Beijing Centergate Technologies: Announcement of Major Litigation Progress.

Jun 14 12:00 ET

Beijing Centergate Technologies: Announcement of the resolution of the third interim shareholders meeting in 2024.

Jun 11 12:00 ET

Beijing Centergate Technologies: Legal Opinion from Beijing Hairun Tianrui Law Firm regarding the third interim shareholder meeting of Beijing Centergate Technologies (Holdings) Co., Ltd. in 2024.

Jun 11 12:00 ET

Beijing Centergate Technologies: Notice on convening the 3rd Extraordinary General Meeting of Shareholders in 2024

May 23 12:00 ET

Beijing Centergate Technologies: Special instructions on redeeming executive performance pay in 2023

May 23 12:00 ET

Beijing Centergate Technologies: Legal Opinion of Beijing Hairun Tianrui Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Zhongguancun Technology Development (Holdings) Co., Ltd.

May 10 12:00 ET

Beijing Centergate Technologies: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 10 12:00 ET

Beijing Centergate Technologies: Notice on the receipt of the “Notice of Acceptance” of the subsidiary company Duoduo Pharmaceutical Ambroxol Hydrochloride Injection from the State Drug Administration

Apr 29 12:00 ET

Zhongguancun: Notice on Convening the 2023 Annual General Meeting of Shareholders (updated)

Apr 22 12:00 ET

Zhongguancun: Announcement on the approval for marketing of the subsidiary Beijing Huasubanbazole API

Apr 22 12:00 ET

Zhongguancun: 2023 Annual General Meeting of Shareholders Meeting Materials

Apr 18 12:00 ET

Zhongguancun: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties

Apr 18 12:00 ET

Zhongguancun: Rules of Procedure for the Board of Directors Meeting (April 2024)

Apr 18 12:00 ET

Zhongguancun: Internal Control Self-Assessment Report

Apr 18 12:00 ET

Zhongguancun: Notice of Annual General Meeting of Shareholders (before update)

Apr 18 12:00 ET